Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 327-335

  Bradfute, Steven B ^a   Swanson, Paul E ^b   Smith, Mark A ^a   Watanabe, Eizo ^c   McDunn, Jonathan E ^c   Hotchkiss, Richard S ^c   Bavari, Sina ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; DEATH RECEPTOR; FAS LIGAND; LIVER ENZYME; PROTEIN BCL 2; PROTEIN BID; APOPTOSIS REGULATORY PROTEIN; BCL 2 LIKE PROTEIN 11; BCL-2-LIKE PROTEIN 11; BID PROTEIN, MOUSE; MEMBRANE PROTEIN; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; ENZYME BLOOD LEVEL; GENE OVEREXPRESSION; IN VIVO STUDY; LIVER CELL; LYMPHOCYTE; MITOCHONDRION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; SURVIVAL RATE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY; VIROLOGY;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; EBOLAVIRUS; FLOW CYTOMETRY; HEMORRHAGIC FEVER, EBOLA; HEPATOCYTES; IN SITU NICK-END LABELING; LYMPHOCYTES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 73949130445     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901231     Document Type: Article

References (52)

1. Zampieri, C. A., N. J. Sullivan, and G. J. Nabel. 2007. Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat. Immunol. 8: 1159-1164.
2. 1978. Ebola haemorrhagic fever in Zaire, 1976. Bull. World Health Organ. 56: 271-293.
3. Baize, S., E. M. Leroy, M. C. Georges-Courbot, M. Capron, J. Lansoud-Soukate, P. Debré, S. P. Fisher-Hoch, J. B. McCormick, and A. J. Georges. 1999. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5: 423-426.
4. Bradfute, S. B., D. R. Braun, J. D. Shamblin, J. B. Geisbert, J. Paragas, A. Garrison, L. E. Hensley, and T. W. Geisbert. 2007. Lymphocyte death in a mouse model of Ebola virus infection. J. Infect. Dis. 196(Suppl 2): S296-S304.
5. Geisbert, T. W., L. E. Hensley, T. R. Gibb, K. E. Steele, N. K. Jaax, and P. B. Jahrling. 2000. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab. Invest. 80: 171-186.
6. Geisbert, T. W., L. E. Hensley, T. Larsen, H. A. Young, D. S. Reed, J. B. Geisbert, D. P. Scott, E. Kagan, P. B. Jahrling, and K. J. Davis. 2003. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 163: 2347-2370.
7. Gibb, T. R., M. Bray, T. W. Geisbert, K. E. Steele, W. M. Kell, K. J. Davis, and N. K. Jaax. 2001. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J. Comp. Pathol. 125: 233-242.
8. Bradfute, S. B., K. L. Warfield, and S. Bavari. 2008. Functional CD8+ T cell responses in lethal Ebola virus infection. J. Immunol. 180: 4058-4066.
9. Parrino, J., R. S. Hotchkiss, and M. Bray. 2007. Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections. Emerg. Infect. Dis. 13: 191-198.
10. Hensley, L. E., H. A. Young, P. B. Jahrling, and T. W. Geisbert. 2002. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol. Lett. 80: 169-179.
11. Yaddanapudi, K., G. Palacios, J. S. Towner, I. Chen, C. A. Sariol, S. T. Nichol, and W. I. Lipkin. 2006. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 20: 2519-2530.
12. Ellis, D. S., I. H. Simpson, D. P. Francis, J. Knobloch, E. T. Bowen, P. Lolik, and I. M. Deng. 1978. Ultrastructure of Ebola virus particles in human liver. J. Clin. Pathol. 31: 201-208.
13. Bowen, E. T., G. S. Platt, D. I. Simpson, L. B. McArdell, and R. T. Raymond. 1978. Ebola haemorrhagic fever: experimental infection of monkeys. Trans. R. Soc. Trop. Med. Hyg. 72: 188-191.
14. Bray, M., K. Davis, T. Geisbert, C. Schmaljohn, and J. Huggins. 1998. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 178: 651-661.
15. Fisher-Hoch, S. P., G. S. Platt, G. H. Neild, T. Southee, A. Baskerville, R. T. Raymond, G. Lloyd, and D. I. Simpson. 1985. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J. Infect. Dis. 152: 887-894.
16. Sullivan, N. J., A. Sanchez, P. E. Rollin, Z. Y. Yang, and G. J. Nabel. 2000. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408: 605-609.
17. Rollin, P. E., D. G. Bausch, and A. Sanchez. 2007. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J. Infect. Dis. 196(Suppl 2): S364-S371.
18. Report of a WHO/International Study Team. 1978. Ebola haemorrhagic fever in Sudan, 1976. Bull. World Health Organ. 56: 247-270.
19. Baskerville, A., E. T. Bowen, G. S. Platt, L. B. McArdell, and D. I. Simpson. 1978. The pathology of experimental Ebola virus infection in monkeys. J. Pathol. 125: 131-138. (Pubitemid 8400311)
20. Ogilvy, S., D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris, and J. M. Adams. 1999. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. U. S. A. 96: 14943-14948.
21. Newton, K., A. W. Harris, M. L. Bath, K. G. Smith, and A. Strasser. 1998. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17: 706-718.
22. Domen, J., K. L. Gandy, and I. L. Weissman. 1998. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 91: 2272-2282. (Pubitemid 28155500)
23. Zaki, S. R., W. J. Shieh, P. W. Greer, C. S. Goldsmith, T. Ferebee, J. Katshitshi, F. K. Tshioko, M. A. Bwaka, R. Swanepoel, P. Calain, et al. 1999. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. J. Infect. Dis. 179(Suppl 1): S36-S47.
24. Ryabchikova, E., L. Kolesnikova, M. Smolina, V. Tkachev, L. Pereboeva, S. Baranova, A. Grazhdantseva, and Y. Rassadkin. 1996. Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis. Arch. Virol. 141: 909-921.
25. Ryabchikova, E. I., L. V. Kolesnikova, and S. V. Luchko. 1999. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J. Infect. Dis. 179(Suppl 1): S199-S202.
26. Nakajima, H., N. Mizuta, I. Fujiwara, K. Sakaguchi, H. Ogata, J. Magae, H. Yagita, and T. Koji. 2008. Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver. Apoptosis 13: 1013-1021.
27. Khai, N. C., T. Takahashi, H. Ushikoshi, S. Nagano, K. Yuge, M. Esaki, T. Kawai, K. Goto, Y. Murofushi, T. Fujiwara, et al. 2006. In vivo hepatic HBEGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF. J. Hepatol. 44: 1046-1054.
28. Legge, K. L., and T. J. Braciale. 2005. Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity 23: 649-659.
29. Bahl, K., S. K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, L. K. Selin, and R. M. Welsh. 2006. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J. Immunol. 176: 4284-4295.
30. Jiang, J., L. L. Lau, and H. Shen. 2003. Selective depletion of nonspecific T cells during the early stage of immune responses to infection. J. Immunol. 171: 4352-4358. (Pubitemid 37238713)
31. McNally, J. M., C. C. Zarozinski, M. Y. Lin, M. A. Brehm, H. D. Chen, and R. M. Welsh. 2001. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75: 5965-5976.
32. Razvi, E. S., Z. Jiang, B. A. Woda, and R. M. Welsh. 1995. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am. J. Pathol. 147: 79-91.
33. Gupta, M., C. Spiropoulou, and P. E. Rollin. 2007. Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell subpopulations in vitro. Virology 364: 45-54.
34. Chang, K. C., J. Unsinger, C. G. Davis, S. J. Schwulst, J. T. Muenzer, A. Strasser, and R. S. Hotchkiss. 2007. Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J. 21: 708-719.
35. Hotchkiss, R. S., and D. W. Nicholson. 2006. Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6: 813-822.
36. Baize, S., E. M. Leroy, E. Mavoungou, and S. P. Fisher-Hoch. 2000. Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system? Apoptosis 5: 5-7.
37. Reed, D. S., L. E. Hensley, J. B. Geisbert, P. B. Jahrling, and T. W. Geisbert. 2004. Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. Viral Immunol. 17: 390-400.
38. Panchal, R. G., S. B. Bradfute, B. D. Peyser, K. L. Warfield, G. Ruthel, D. Lane, T. A. Kenny, A. O. Anderson, W. C. Raschke, and S. Bavari. 2009. Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infection. Cell Host Microbe 6: 162-173.
39. Hamrouni, A., A. Olsson, G. J. Wiegers, and A. Villunger. 2007. Impact of cellular lifespan on the T cell receptor repertoire. Eur. J. Immunol. 37: 1978-1985.
40. Hotchkiss, R. S., P. E. Swanson, C. M. Knudson, K. C. Chang, J. P. Cobb, D. F. Osborne, K. M. Zollner, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol. 162: 4148-4156.
41. Fischer, S. F., P. Bouillet, K. O'Donnell, A. Light, D. M. Tarlinton, and A. Strasser. 2007. Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells. Blood 110: 3978-3984.
42. Pandiyan, P., and M. J. Lenardo. 2008. The control of CD4+CD25+Foxp3+ regulatory T cell survival. Biol. Direct 3: 6.
43. Geisbert, T. W., P. Pushko, K. Anderson, J. Smith, K. J. Davis, and P. B. Jahrling. 2002. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg. Infect. Dis. 8: 503-507.
44. Bray, M. 2001. The role of the Type I interferon response in the resistance of mice to filovirus infection. J. Gen. Virol. 82: 1365-1373.
45. Bray, M., J. L. Raymond, T. Geisbert, and R. O. Baker. 2002. 3-deazaneplanocin A induces massively increased interferon-a production in Ebola virus-infected mice. Antiviral Res. 55: 151-159.
46. Jones, S. M., U. Stroher, L. Fernando, X. Qiu, J. Alimonti, P. Melito, M. Bray, H. D. Klenk, and H. Feldmann. 2007. Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever. J. Infect. Dis. 196(Suppl 2): S404-S412.
47. Olinger, G. G., M. A. Bailey, J. M. Dye, R. Bakken, A. Kuehne, J. Kondig, J. Wilson, R. J. Hogan, and M. K. Hart. 2005. Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins. J. Virol. 79: 14189-14196.
48. Warfield, K. L., C. M. Bosio, B. C. Welcher, E. M. Deal, M. Mohamadzadeh, A. Schmaljohn, M. J. Aman, and S. Bavari. 2003. Ebola virus-like particles protect from lethal Ebola virus infection. Proc. Natl. Acad. Sci. U. S. A. 100: 15889-15894.
49. Warfield, K. L., G. Olinger, E. M. Deal, D. L. Swenson, M. Bailey, D. L. Negley, M. K. Hart, and S. Bavari. 2005. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection. J. Immunol. 175: 1184-1191.
50. Warfield, K. L., J. G. Perkins, D. L. Swenson, E. M. Deal, C. M. Bosio, M. J. Aman, W. M. Yokoyama, H. A. Young, and S. Bavari. 2004. Role of natural killer cells in innate protection against lethal ebola virus infection. J. Exp. Med. 200: 169-179.
51. Warfield, K. L., D. L. Swenson, G. G. Olinger, D. K. Nichols, W. D. Pratt, R. Blouch, D. A. Stein, M. J. Aman, P. L. Iversen, and S. Bavari. 2006. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog. 2: e1.
52. Wilson, J. A., and M. K. Hart. 2001. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein. J. Virol. 75: 2660-2664.